HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,981-7,992 of 27,277
Other study type icon
CompletedNCT03496285

Accumbofrontal Tract Study in 2 Populations of people with Eating disorders and Obsessional Compulsive Disorder and Healthy Volunteer

Official study title

Multimodal MRI Study of Accumbofrontal Tract in Anorexia Nervosa and Obessional Compulsive Disorder : Search for Structural and Functional Changes Between Orbito-frontal Cortex and Accumbens Nucleus Subdivisions

This study has finished and is no longer accepting participants.

In Poitiers
Eating disordersInterventional studyAges 18–65
Countries
France
Sponsor
Poitiers University Hospital
Drug study icon
CompletedNCT02108990

Acetaminophen and Social Processes

Official study title

Acetaminophen and Social Pain in Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In Columbus
Personality disordersMedication studyAges 18–50
Countries
United States
Sponsor
Ohio State University
Device study icon
CompletedNCT00534781

Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement

Official study title

Radiofrequency-based Plasma Microdebridement Compared to Surgical Microdebridement for Treating Achilles Tendinosis: A Prospective, Randomized, Controlled Multi-Center Study"

This study has finished and is no longer accepting participants.

Multiple locations, including Baltimore
BipolarityDevice studyAges 18+
Countries
United States
Sponsor
ArthroCare Corporation
Drug study icon
CompletedNCT00490516

ACP-104 or placebo for acute psychosis in schizophrenia

About this title

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

Read the official source — NCT00490516
What is this study about?

Researchers compared ACP-104 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.